Nasu-Hakola disease: a rare entity in Italy. Critical review of the literature
- PMID: 15595711
Nasu-Hakola disease: a rare entity in Italy. Critical review of the literature
Abstract
Nasu-Hakola disease (NHD, polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, PLOSL) is a recessively inherited disorder characterized by systemic bone cysts and progressive presenile dementia associated with sclerosing encephalopathy. The disease has a worldwide distribution, but most patients have been reported in Finland and in Japan; in Italy there are anecdotal reports. The combination of neuropsychiatric symptoms and bone cysts is unique to this disease, which we believe to be underestimated in Italy. The molecular defect has been identified in loss-of-function mutations in the TYROBP gene in Finnish and in Japanese patients, and in the TREM2 gene in other families of different ethnic origins. We reviewed the international literature to define better the diagnostic steps and to draw the attention of neurologists and orthopaedic specialists to the disease. The identification of new cases followed by appropriate genetic counselling, genetic analysis, and study of the territorial distribution of affected patients could be a good strategy to follow in order to improve understanding of the disease.
Similar articles
-
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.Nat Genet. 2000 Jul;25(3):357-61. doi: 10.1038/77153. Nat Genet. 2000. PMID: 10888890
-
Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL): a new report of an Italian woman and review of the literature.J Neurol Sci. 2013 Mar 15;326(1-2):115-9. doi: 10.1016/j.jns.2013.01.021. Epub 2013 Feb 9. J Neurol Sci. 2013. PMID: 23399524 Review.
-
A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature.Neurobiol Aging. 2017 May;53:194.e13-194.e22. doi: 10.1016/j.neurobiolaging.2017.01.015. Epub 2017 Jan 20. Neurobiol Aging. 2017. PMID: 28214109 Review.
-
A novel compound heterozygous mutation in the DAP12 gene in a patient with Nasu-Hakola disease.J Neurol Sci. 2007 Jan 15;252(1):88-91. doi: 10.1016/j.jns.2006.09.019. Epub 2006 Nov 27. J Neurol Sci. 2007. PMID: 17125796
-
[Molecular Pathogenesis of Nasu-Hakola Disease Brain Lesions].Brain Nerve. 2016 May;68(5):543-50. doi: 10.11477/mf.1416200435. Brain Nerve. 2016. PMID: 27156507 Japanese.
Cited by
-
Age Matching Is Essential for the Study of Cerebrospinal Fluid sTREM2 Levels and Alzheimer's Disease Risk: A Meta-Analysis.Front Aging Neurosci. 2021 Nov 12;13:775432. doi: 10.3389/fnagi.2021.775432. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34867303 Free PMC article.
-
Word list learning in patients with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy.Dement Geriatr Cogn Dis Extra. 2013 Jan;3(1):10-5. doi: 10.1159/000346857. Epub 2013 Feb 16. Dement Geriatr Cogn Dis Extra. 2013. PMID: 23569454 Free PMC article.
-
Proteomic analysis of lymphoblastoid cells from Nasu-Hakola patients: a step forward in our understanding of this neurodegenerative disorder.PLoS One. 2014 Dec 3;9(12):e110073. doi: 10.1371/journal.pone.0110073. eCollection 2014. PLoS One. 2014. PMID: 25470616 Free PMC article.
-
Bone-brain interaction: mechanisms and potential intervention strategies of biomaterials.Bone Res. 2025 Mar 17;13(1):38. doi: 10.1038/s41413-025-00404-5. Bone Res. 2025. PMID: 40097409 Free PMC article. Review.
-
A Shotgun Proteomic Platform for a Global Mapping of Lymphoblastoid Cells to Gain Insight into Nasu-Hakola Disease.Int J Mol Sci. 2021 Sep 15;22(18):9959. doi: 10.3390/ijms22189959. Int J Mol Sci. 2021. PMID: 34576123 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Medical